• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2022 National Institute for Health and Care Excellence (NICE) Zanubrutinib for treating Waldenstrom's macroglobulinaemia. NICE technology appraisal guidance 833
2022 National Institute for Health and Care Excellence (NICE) SQ HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (terminated appraisal). NICE technology appraisal guidance 834
2022 National Institute for Health and Care Excellence (NICE) Fostamatinib for treating refractory chronic immune thrombocytopenia. NICE technology appraisal guidance 835
2022 National Institute for Health and Care Excellence (NICE) Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy. NICE technology appraisal guidance 836
2022 National Institute for Health and Care Excellence (NICE) Pembrolizumab for adjuvant treatment of resected stage 2B or 2C melanoma. NICE technology appraisal guidance 837
2022 National Institute for Health and Care Excellence (NICE) Slow-release potassium bicarbonate-potassium citrate for treating distal renal tubular acidosis (terminated appraisal). NICE technology appraisal guidance 838
2022 National Institute for Health and Care Excellence (NICE) Ruxolitinib for treating acute graft versus host disease refractory to corticosteroids (terminated appraisal). NICE technology appraisal guidance 839
2022 National Institute for Health and Care Excellence (NICE) Ruxolitinib for treating chronic graft versus host disease refractory to corticosteroids (terminated appraisal). NICE technology appraisal guidance 840
2022 National Institute for Health and Care Excellence (NICE) Carfilzomib with daratumumab and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal). NICE technology appraisal guidance 841
2022 National Institute for Health and Care Excellence (NICE) Tisagenlecleucel for treating follicular lymphoma after 2 or more therapies (terminated appraisal). NICE technology appraisal guidance 842
2022 National Institute for Health and Care Excellence (NICE) Luspatercept for treating anaemia caused by beta-thalassaemia (terminated appraisal). NICE technology appraisal guidance 843
2022 National Institute for Health and Care Excellence (NICE) Luspatercept for treating anaemia caused by myelodysplastic syndromes (terminated appraisal). NICE technology appraisal guidance 844
2022 National Institute for Health and Care Excellence (NICE) Mepolizumab for treating eosinophilic granulomatosis with polyangiitis (terminated appraisal). NICE technology appraisal guidance 845
2022 National Institute for Health and Care Excellence (NICE) Mepolizumab for treating severe hypereosinophilic syndrome (terminated appraisal). NICE technology appraisal guidance 846
2022 National Institute for Health and Care Excellence (NICE) Mepolizumab for treating severe chronic rhinosinusitis with nasal polyps (terminated appraisal). NICE technology appraisal guidance 847
2022 National Institute for Health and Care Excellence (NICE) Cemiplimab for untreated PD-L1-positive advanced or metastatic non-small-cell lung cancer (terminated appraisal). NICE technology appraisal guidance 848
2022 National Institute for Health and Care Excellence (NICE) Cabozantinib for previously treated advanced hepatocellular carcinoma. NICE technology appraisal guidance 849
2022 National Institute for Health and Care Excellence (NICE) Amivantamab for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapy. NICE technology appraisal guidance 850
2022 National Institute for Health and Care Excellence (NICE) Pembrolizumab for neoadjuvant and adjuvant treatment of triple-negative early or locally advanced breast cancer. NICE technology appraisal guidance 851
2022 National Institute for Health and Care Excellence (NICE) Trifluridinetipiracil for treating metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma after 2 or more treatments. NICE technology appraisal guidance 852
2022 National Institute for Health and Care Excellence (NICE) Avatrombopag for treating primary chronic immune thrombocytopenia. NICE technology appraisal guidance 853
2022 National Institute for Health and Care Excellence (NICE) Esketamine nasal spray for treatment-resistant depression. NICE technology appraisal guidance 854
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Advanced lymphoedema: can non-medicinal procedures relieve symptoms?]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Depression in children and adolescents: does psychotherapy lead to better results compared to other therapies?]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cystitis: do herbal remedies help with recurring, uncomplicated cystitis?]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Heart disease in children: can children be helped to cope with their illness through psychological support?]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Social isolation in the elderly: what measures can prevent or counteract social isolation?]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Blood values: do older people benefit from regular determination of vitamin B12 and vitamin D levels in the blood?]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Mobility disorders: does the Feldenkrais method help?]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Developmental vision disorders: do children and adolescents benefit from active vision training?]
2022 Haute Autorite de sante (HAS) [Transcranial magnetic stimulation (rTMS) in the treatment of adult treatment-resistant depression]
2022 National Institute for Health and Care Excellence (NICE) Tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosis. NICE interventional procedures guidance 746
2022 National Institute for Health and Care Excellence (NICE) Ab interno canaloplasty for open-angle glaucoma. NICE interventional procedures guidance 745
2022 National Institute for Health and Care Excellence (NICE) Percutaneous ultrasound-guided microwave ablation for symptomatic benign thyroid nodules. NICE interventional procedures guidance 743
2022 National Institute for Health and Care Excellence (NICE) Extracorporeal shockwave therapy for calcific tendinopathy in the shoulder. NICE interventional procedures guidance 742
2022 National Institute for Health and Care Excellence (NICE) Transcutaneous electrical stimulation of the supraorbital nerve for treating and preventing migraine. NICE interventional procedures guidance 740
2022 National Institute for Health and Care Excellence (NICE) YAG laser vitreolysis for symptomatic vitreous floaters. NICE interventional procedures guidance 741
2022 National Institute for Health and Care Excellence (NICE) Neurostimulation of lumbar muscles for refractory non-specific chronic low back pain. NICE interventional procedures guidance 739
2022 National Institute for Health and Care Excellence (NICE) Prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia. NICE interventional procedures guidance 737
2022 National Institute for Health and Care Excellence (NICE) Removal, preservation and subsequent reimplantation of ovarian tissue to prevent symptoms from the menopause. NICE interventional procedures guidance 738
2022 National Institute for Health and Care Excellence (NICE) Focal resurfacing implants to treat articular cartilage damage in the knee. NICE interventional procedures guidance 734
2022 National Institute for Health and Care Excellence (NICE) Transcutaneous electrical neuromuscular stimulation for urinary incontinence. NICE interventional procedures guidance 735
2022 National Institute for Health and Care Excellence (NICE) Superficial venous arterialisation for chronic limb threatening ischaemia. NICE interventional procedures guidance 736
2022 National Institute for Health and Care Excellence (NICE) Bioresorbable stent implantation to treat coronary artery disease. NICE interventional procedures guidance 732
2022 National Institute for Health and Care Excellence (NICE) Aortic remodelling hybrid stent insertion during surgical repair of an acute type A aortic dissection. NICE interventional procedures guidance 733
2022 National Institute for Health and Care Excellence (NICE) Transcatheter tricuspid valve annuloplasty for tricuspid regurgitation. NICE interventional procedures guidance 730
2022 National Institute for Health and Care Excellence (NICE) Transcatheter tricuspid valve leaflet repair for tricuspid regurgitation. NICE interventional procedures guidance 731
2022 National Institute for Health and Care Excellence (NICE) Vertebral body tethering for idiopathic scoliosis in children and young people. NICE interventional procedures guidance 728
2022 National Institute for Health and Care Excellence (NICE) Nerve graft for corneal denervation. NICE interventional procedures guidance 729
2022 National Institute for Health and Care Excellence (NICE) Synthetic cartilage implant insertion for first metatarsophalangeal joint osteoarthritis (hallux rigidus). NICE interventional procedures guidance 727
2022 National Institute for Health and Care Excellence (NICE) Endoanchoring systems in endovascular aortic aneurysm repair. NICE interventional procedures guidance 725
2022 National Institute for Health and Care Excellence (NICE) Supercapsular percutaneously assisted total hip arthroplasty for osteoarthritis. NICE interventional procedures guidance 726
2022 National Institute for Health and Care Excellence (NICE) Personalised external aortic root support (PEARS) using mesh to prevent aortic root expansion and aortic dissection in people with Marfan syndrome. NICE interventional procedures guidance 724
2022 National Institute for Health and Care Excellence (NICE) Liposuction for chronic lymphoedema. NICE interventional procedures guidance 723
2022 National Institute for Health and Care Excellence (NICE) Intramedullary distraction for upper limb lengthening. NICE interventional procedures guidance 722
2022 National Institute for Health and Care Excellence (NICE) Liposuction for chronic lipoedema. NICE interventional procedures guidance 721
2022 National Institute for Health and Care Excellence (NICE) Percutaneous insertion of a cystic duct stent after cholecystostomy for acute calculous cholecystitis. NICE interventional procedures guidance 720
2022 National Institute for Health and Care Excellence (NICE) Endoscopic full thickness removal of gastrointestinal stromal tumours of the stomach. NICE interventional procedures guidance 717
2022 National Institute for Health and Care Excellence (NICE) Intramedullary distraction for lower limb lengthening. NICE interventional procedures guidance 718
2022 National Institute for Health and Care Excellence (NICE) Endoscopic balloon dilation for subglottic or tracheal stenosis. NICE interventional procedures guidance 719
2022 National Institute for Health and Care Excellence (NICE) Stereotactic radiosurgery for trigeminal neuralgia. NICE interventional procedures guidance 715
2022 National Institute for Health and Care Excellence (NICE) Microwave ablation for primary or metastatic cancer in the lung. NICE interventional procedures guidance 716
2022 HTA South [Endovascular valve repair in severe mitral insufficiency]
2022 HTA South [Cardiac Contractility Modulation device treatment in heart failure]
2022 HTA South [Music intervention for adult intensive care patients]
2022 HTA South [Allograft in peripheral nerve surgery]
2022 HTA South [Conductive education in cerebral palsy]
2022 HTA South [Is there a difference in outcome between closing the palate in one or two stages?]
2022 HTA South [Blood group matching with genotyping]
2022 National Institute for Health and Care Excellence (NICE) KardiaMobile for detecting atrial fibrillation. NICE medical technologies guidance 64
2022 National Institute for Health and Care Excellence (NICE) Memokath 051 Ureter stent for ureteric obstruction. NICE medical technologies guidance 75
2022 National Institute for Health and Care Excellence (NICE) Optilume for treating recurrent bulbar urethral strictures. NICE medical technologies guidance 73
2022 National Institute for Health and Care Excellence (NICE) GreenLight XPS for treating benign prostatic hyperplasia. NICE medical technologies guidance 74
2022 National Institute for Health and Care Excellence (NICE) Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancer. NICE medical technologies guidance 72
2022 National Institute for Health and Care Excellence (NICE) Faecal microbiota transplant for recurrent Clostridioides difficile infection. NICE medical technologies guidance 71
2022 National Institute for Health and Care Excellence (NICE) Sleepio to treat insomnia and insomnia symptoms. NICE medical technologies guidance 70
2022 National Institute for Health and Care Excellence (NICE) myCOPD for managing chronic obstructive pulmonary disease. NICE medical technologies guidance 68
2022 National Institute for Health and Care Excellence (NICE) UroShield for preventing catheter-associated urinary tract infections. NICE medical technologies guidance 69
2022 National Institute for Health and Care Excellence (NICE) Prontosan for treating acute and chronic wounds. NICE medical technologies guidance 67
2022 National Institute for Health and Care Excellence (NICE) 3C Patch for treating diabetic foot ulcers. NICE medical technologies guidance 66
2022 National Institute for Health and Care Excellence (NICE) Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care. NICE medical technologies guidance 65
2022 National Institute for Health and Care Excellence (NICE) PLGF-based testing to help diagnose suspected preterm pre-eclampsia. NICE diagnostics guidance 49
2022 National Institute for Health and Care Excellence (NICE) PredictSURE IBD and IBDX to guide treatment of Crohn's disease. NICE diagnostics guidance 45
2022 National Institute for Health and Care Excellence (NICE) EarlyCDT Lung for assessing risk of lung cancer in solid lung nodules. NICE diagnostics guidance 46
2022 Canary Health Service [Efficacy and safety of aromatherapy]
2022 Canary Health Service [Effectiveness and safety of relaxation techniques based on the induction of bodily sensations]
2022 National Institute for Health and Care Excellence (NICE) Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment). NICE diagnostics guidance 47
2022 Health Information and Quality Authority (HIQA) International review of clinical guidelines and models of care for long COVID
2022 Health Information and Quality Authority (HIQA) Update processes for guidelines – systematic review
2022 Health Information and Quality Authority (HIQA) Clinical and cost-effectiveness of healthcare-associated infection interventions: a systematic review
2022 Health Information and Quality Authority (HIQA) Budget impact analysis – National Clinical Guideline: Infection prevention and control
2022 Norwegian Institute of Public Health (NIPH) Zephyr® valves system in the treatment of emphysema: a single technology assessment
2021 Health Council of the Netherlands Gezondheidsraad (GR) [Influenza vaccination: review of indications]
2021 Haute Autorite de sante (HAS) [Remote monitoring of patients with an implantable loop recorder]
2021 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Perioperative antibiotics for prevention of infections in arterial reconstructions with vascular prostheses]
2021 NIHR Health Technology Assessment programme A comparison of general anaesthesia versus awake-regional anaesthesia in infancy: an international, multicentre, randomised controlled equivalence trial; the GAS study
2021 Center for Drug Evaluation (CDE) [Health economic evaluation of three listed anti-cancer medications]
2021 Center for Drug Evaluation (CDE) [Review of international guidelines and comparative effectiveness of high cost antidiabetes drugs]
2021 Center for Drug Evaluation (CDE) [Descriptive study and comparative effectiveness of listed medications for osteoporosis on new osteoporotic fracture event in osteoporosis patients by using National Health Insurance claim database]
2021 Center for Drug Evaluation (CDE) [A systematic review of the comparative efficacy and cost-effectiveness of current listed statins in Taiwan]